MedPath

To manage the garbhini chhardi (vomiting in pregnancy) with the help of an ayurvedic formulation.

Phase 2
Not yet recruiting
Conditions
Health Condition 1: O210- Mild hyperemesis gravidarum
Registration Number
CTRI/2024/07/071568
Lead Sponsor
Dr Sakshi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients having confirm diagnosis of pregnancy .

2 Patients presenting the classical symptoms of

Garbhini chhardi.

3 Patients presenting with symptoms of Emesis

Gravidarum.

4 All patient diagnosed with Chhardi during first

trimester (both primigravida and multigravida).

Exclusion Criteria

1 Patients with Hyperemesis Gravidarum.

2 Patients with Hemoglobin less than 8gm%.

3 Vomiting caused due to any medical and surgical condition.

4 Vomiting caused due to systemic disorders like acid peptic ulcer,

appendicitis, cholecystitis etc.

5 Patient with PIH (Pregnancy induced hypertension), GDM (Gestational

Diabetes Mellitus) and High-risk pregnancies (Molar pregnancy, Ectopic

pregnancy).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 To evaluate the efficacy of Matulungadi Avaleha in comparison to Tab. Doxinate in the management of Garbhini Chhardi w,s.r to emesis gravidarum. <br/ ><br>2 Improvement in subjective and objective criteria of patient.Timepoint: follow up after 21 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1 To study the garbhini chhardi in different ayurvedic texts & correlate with emesis gravidarum. <br/ ><br>2 To assess improvement in signs & symptoms such as anorexia,nausea,vomiting etc as per assessment criteria. <br/ ><br>3. to find out an ayurvedic approach for the management of garbhini chhardi. <br/ ><br>Timepoint: Follow up during the treatment- will be on 8th day, 15th day, 21st day. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath